Migraine

Migraine affects many individuals worldwide, yet many patients remain undiagnosed or undertreated, highlighting a widespread, unmet need that calls for new drugs and pathways for migraine treatment.

Using telemedicine for migraine treatment could improve physician productivity as well as patient access, according to an abstract presented at the 2019 American Headache Society Annual Meeting.

A recent study sought to determine if there was an association between food insecurity, or the fear that your food will run out before you have enough money to purchase more, and migraine, which commonly affects 1 in 6 individuals, among young adults in the United States.

Abraham Nagy, MD, chair of neurology at University of Las Vegas and director of Nevada Headache Institute discusses how better lifestyle choices can improve headaches.

A new study said there are greater risks of several adverse pregnancy outcomes for women with migraines than those without, including elevated blood pressure, miscarriage, caesareans, preterm births, and infants with low birth weight.

Shoshana Lipson, a patient advocate and founder of the “CGRP & Migraine Community ” on Facebook explains what she sees as the biggest takeaways from the migraine peer exchange that she participated in.

Stephen Silberstein, MD, director of the Jefferson Headache Center, discusses patient reactions to being prescribed a CGRP inhibitor.

A recent study examined cognitive changes in a type of migraine termed chronic migraine with medication overuse headache (CM-MOH).

Sensory processing difficulties are seen among children with migraine, according to a recently published study, which said that their quality of life is predicted by both headache-related disability and sensory processing difficulties.

Earlier this month, the FDA approved the first ever migraine drug, galcanezumab-gnlm (Emgality, Lilly) indicated to treat cluster headaches.

Research shows that primary care physicians prescribe preventive therapy for migraine less often than migraine specialists.

Study findings are indicating that patients with migraine are at an increased risk of Bell palsy, and the increased risk varies among age groups.

Wayne Burton, MD, former global corporate medical director for American Express, discusses what he views as the key takeaways from a migraine peer exchange he recently participated in.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The FDA approved a smartphone-controlled medical device that claims to treat migraine.

Higher migraine-related costs were the top indicators of a patient having chronic migraine, according to a poster presented at ISPOR 2019.

In a recent study, researchers looked to determine the effect of erenumab (Aimovig) on health-related quality of life (HRQOL), headache impact, and disability in patients with chronic migraine.

Shoshana Lipson, a patient advocate and founder of the “CGRP & Migraine Community ” on Facebook explains the patient perspective of CGRP inhibitors.

In a large survey of patients with migraine taking an oral, acute prescription migraine medication, most had unmet needs, according to survey results presented recently at the annual meeting of the American Academy of Neurology.

A recent study examined associations of comorbid migraine with other painful physical symptoms in patients with major depressive disorder at 2 years, and results suggested there might be benefit to integrating care for those with both depression and headache.

Wayne Burton, MD, former global corporate medical director, American Express, explains the benefits of migraine education programs in the workplace.